Reasons for breast cancer heterogeneity

Journal of Biology

Volumn 7, Issue 2, 2008, Pages

  Bertucci, François ^a   Birnbaum, Daniel ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA;

ARTICLE; BREAST CANCER; CARCINOGENICITY; GENE AMPLIFICATION; GENE DELETION; GENE EXPRESSION; GENE MUTATION; GENETIC HETEROGENEITY; PRIORITY JOURNAL; PROTEIN PROCESSING; ANIMAL; BIOSYNTHESIS; BREAST TUMOR; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; PATHOLOGY; PHYSIOLOGY; REVIEW;

ANIMALS; BREAST NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC HETEROGENEITY; HUMANS; MICRORNAS;

EID: 42449097765     PISSN: None     EISSN: 14754924     Source Type: Journal    
DOI: 10.1186/jbiol67     Document Type: Article

References (21)

1. High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer. SF Chin AE Teschendorff JC Marioni Y Wang NL Barbosa-Morais NP Thorne JL Costa SE Pinder MA van de Wiel AR Green IO Ellis PL Porter S Tavaré JD Brenton B Ylstra C Caldas, Genome Biol 2007 8 R215 17925008 10.1186/gb-2007-8-10-r215
2. MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype. C Blenkiron LD Goldstein NP Thorne I Spiteri SF Chin MJ Dunning NL Barbosa-Morais AE Teschendorff AR Green IO Ellis S Tavaré C Caldas EA Miska, Genome Biol 2007 8 R214 17922911 10.1186/gb-2007-8-10-r214
3. Patterns of somatic mutation in human cancer genomes. C Greenman P Stephens R Smith GL Dalgliesh C Hunter G Bignell H Davies J Teague A Butler C Stevens S Edkins S O'Meara I Vastrik EE Schmidt T Avis S Barthorpe G Bhamra G Buck B Choudhury J Clements J Cole E Dicks S Forbes K Gray K Halliday R Harrison K Hills J Hinton A Jenkinson D Jones, Nature 2007 446 153 158 10.1038/nature05610 17344846 (Pubitemid 46398669)
4. The genomic landscapes of human breast and colorectal cancers. LD Wood DW Parsons S Jones J Lin T Sjöblom RJ Leary D Shen SM Boca T Barber J Ptak N Silliman S Szabo Z Dezso V Ustyanksky T Nikolskaya Y Nikolsky R Karchin PA Wilson JS Kaminker Z Zhang R Croshaw J Willis D Dawson M Shipitsin JK Willson S Sukumar K Polyak BH Park CL Pethiyagoda PV Pant, Science 2007 318 1108 1113 10.1126/science.1145720 17932254 (Pubitemid 350134889)
5. Integrated profiling of basal and luminal A breast cancers. J Adélade P Finetti I Bekhouche L Repellini J Geneix F Sircoulomb E Charafe-Jauffret N Cervera J Desplans D Parzy E Schoenmakers P Viens J Jacquemier D Birnbaum F Bertucci M Chaffanet, Cancer Res 2007 67 11565 11575 10.1158/0008-5472.CAN-07-2536 18089785
6. Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. K Chin S DeVries J Fridlyand PT Spellman R Roydasgupta WL Kuo A Lapuk RM Neve Z Qian T Ryder F Chen H Feiler T Tokuyasu C Kingsley S Dairkee Z Meng K Chew D Pinkel A Jain BM Ljung L Esserman DG Albertson FM Waldman JW Gray, Cancer Cell 2006 10 529 541 10.1016/j.ccr.2006.10.009 17157792
7. Genome-wide association study identifies novel breast cancer susceptibility loci. DF Easton KA Pooley AM Dunning PD Pharoah D Thompson DG Ballinger JP Struewing J Morrison H Field R Luben N Wareham S Ahmed CS Healey R Bowman SEARCH collaborators KB Meyer CA Haiman LK Kolonel BE Henderson L Le Marchand P Brennan S Sangrajrang V Gaborieau F Odefrey CY Shen PE Wu HC Wang D Eccles DG Evans J Peto, Nature 2007 447 1087 1093 10.1038/nature05887 17529967 (Pubitemid 47014426)
8. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. DJ Hunter P Kraft KB Jacobs DG Cox M Yeager SE Hankinson S Wacholder Z Wang R Welch A Hutchinson J Wang K Yu N Chatterjee N Orr WC Willett GA Colditz RG Ziegler CD Berg SS Buys CA McCarty HS Feigelson EE Calle MJ Thun RB Hayes M Tucker DS Gerhard JF Fraumeni Jr RN Hoover G Thomas SJ Chanock, Nat Genet 2007 39 870 874 10.1038/ng2075 17529973 (Pubitemid 47014500)
9. Molecular portraits of human breast tumours. CM Perou T Sørlie MB Eisen M van de Rijn SS Jeffrey CA Rees JR Pollack DT Ross H Johnsen LA Akslen O Fluge A Pergamenschikov C Williams SX Zhu PE Lønning AL Børresen-Dale PO Brown D Botstein, Nature 2000 406 747 752 10.1038/35021093 10963602
10. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. T Sørlie CM Perou R Tibshirani T Aas S Geisler H Johnsen T Hastie MB Eisen M van de Rijn SS Jeffrey T Thorsen H Quist JC Matese PO Brown D Botstein P Eystein Lønning A-L Børresen-Dale, Proc Natl Acad Sci USA 2001 98 10869 10874 11553815 10.1073/pnas.191367098 (Pubitemid 32878711)
11. Sixteen-kinase gene expression identifies luminal breast cancers with poor prognosis. P Finetti N Cervera E Charafe-Jauffret C Chabannon C Charpin M Chaffanet J Jacquemier P Viens D Birnbaum F Bertucci, Cancer Res 2008 68 767 776 10.1158/0008-5472.CAN-07-5516 18245477
12. Genes harbouring susceptibility SNPs are differentially expressed in the breast cancer subtypes. SH Nordgard FE Johansen GI Alnaes B Naume AL Borresen-Dale VN Kristensen, Breast Cancer Res 2007 9 113 18036273 10.1186/bcr1784
13. Triple-negative breast cancer: therapeutic options. S Cleator W Heller RC Coombes, Lancet Oncol 2007 8 235 244 10.1016/S1470-2045(07)70074-8 17329194 (Pubitemid 46291713)
14. let-7 regulates self renewal and tumorigenicity of breast cancer cells. F Yu H Yao P Zhu X Zhang Q Pan C Gong Y Huang X Hu F Su J Lieberman E Song, Cell 2007 131 1109 1123 10.1016/j.cell.2007.10.054 18083101 (Pubitemid 350235025)
15. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. L Ma J Teruya-Feldstein RA Weinberg, Nature 2007 449 682 688 10.1038/nature06174 17898713 (Pubitemid 47552092)
16. Endogenous human microRNAs that suppress breast cancer metastasis. SF Tavazoie C Alarcon T Oskarsson D Padua Q Wang PD Bos WL Gerald J Massague, Nature 2008 451 147 152 10.1038/nature06487 18185580
17. miRNAs in cancer: approaches, aetiology, diagnostics and therapy. C Blenkiron EA Miska, Hum Mol Genet 2007 16 Spec. no. 1 R106 113 10.1093/hmg/ddm056 17613543 (Pubitemid 47241849)
18. MicroRNA-implications for cancer. S Sassen EA Miska C Caldas, Virchows Arch 2008 452 1 10 18040713 10.1007/s00428-007-0532-2
19. Altered microRNA expression confined to specific epithelial cell subpopulations in breast cancer. LF Sempere M Christensen A Silahtaroglu M Bak CV Heath G Schwartz W Wells S Kauppinen CN Cole, Cancer Res 2007 67 11612 11620 10.1158/0008-5472.CAN-07-5019 18089790
20. MicroRNA expression profiles classify human cancers. J Lu G Getz EA Miska E Alvarez-Saavedra J Lamb D Peck A Sweet-Cordero BL Ebert RH Mak AA Ferrando JR Downing T Jacks HR Horvitz TR Golub, Nature 2005 435 834 838 10.1038/nature03702 15944708 (Pubitemid 40839735)
21. A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. GA Calin M Ferracin A Cimmino G Di Leva M Shimizu SE Wojcik MV Iorio R Visone NI Sever M Fabbri R Iuliano T Palumbo F Pichiorri C Roldo R Garzon C Sevignani L Rassenti H Alder S Volinia CG Liu TJ Kipps M Negrini CM Croce, N Engl J Med 2005 353 1793 1801 10.1056/NEJMoa050995 16251535 (Pubitemid 41549891)